Spearhead Capital Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$2.09M Sell
4,141
-17,243
-81% -$9.07M 2.27% 9
2022
Q2
$11M Sell
21,384
-2,631
-11% -$1.32M 1.64% 17
2022
Q1
$12.2M Buy
24,015
+664
+3% +$320K 1.52% 21
2021
Q4
$11.7M Buy
23,351
+415
+2% +$188K 1.42% 21
2021
Q3
$8.96M Buy
22,936
+490
+2% +$203K 1.19% 39
2021
Q2
$8.99M Buy
22,446
+278
+1% +$111K 1.22% 34
2021
Q1
$8.25M Buy
22,168
+1,530
+7% +$530K 1.22% 39
2020
Q4
$7.24M Buy
20,638
+1,393
+7% +$467K 1.15% 32
2020
Q3
$6M Buy
19,245
+473
+3% +$145K 1.15% 32
2020
Q2
$5.54M Buy
18,772
+934
+5% +$268K 1.18% 34
2020
Q1
$4.45M Sell
17,838
-553
-3% -$152K 1.28% 34
2019
Q4
$5.41M Buy
18,391
+1,304
+8% +$341K 1.34% 23
2019
Q3
$3.71M Buy
17,087
+1,818
+12% +$439K 1.03% 56
2019
Q2
$3.73M Buy
15,269
+1,886
+14% +$454K 1.09% 52
2019
Q1
$3.31M Buy
+13,383
New +$3.41M 1% 55

Other funds holding UNH

Spearhead Capital Advisors's UNH Position: Q3 2022 in Review

Spearhead Capital Advisors reduced its UnitedHealth (UNH) stake by 81% in Q3 2022, selling an estimated $9.07M and leaving 4,141 shares worth $2.09M. The position accounts for 2.27% of the portfolio, ranked #9.

Spearhead Capital Advisors first reported a position in UNH in Q1 2019 and has held it in 15 quarters since. The position peaked at $12.2M in Q1 2022. 2,994 funds tracked by Wall St. Rank hold UNH as of Q3 2022.

  • Spearhead Capital Advisors held 4,141 shares of UnitedHealth worth $2.09M as of Q3 2022.
  • Spearhead Capital Advisors sold 17,243 UnitedHealth shares in Q3 2022, an estimated $9.07M.
  • UnitedHealth made up 2.27% of Spearhead Capital Advisors's portfolio in Q3 2022, its #9 holding.
  • Spearhead Capital Advisors first reported a position in UnitedHealth in Q1 2019 and has held it in 15 quarters since.
  • Spearhead Capital Advisors's UnitedHealth position peaked at $12.2M in Q1 2022.
  • 2,994 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2022.

Based on Spearhead Capital Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.